Navigation Links
Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China
Date:2/4/2010

DURHAM, N.C., Feb. 4 /PRNewswire/ -- Gorbec Pharmaceutical Services, a rapidly expanding contract developer and manufacturer of prescription pharmaceutical products, is opening a GMP-compliant analytical laboratory in Yantai, China.  This new facility will expand Gorbec's current services for analytical method development and testing.  Gorbec is taking this action to better serve its U.S. customer base as well as develop a presence in the emerging Asian market.

Gorbec currently provides complete development, regulatory, analytical, and manufacturing services for U.S.-based customers.  Gorbec's future plans call for an increased capacity to develop and submit New Drug Applications (NDA'S) and will require an expansion of analytical services.  In an effort to improve efficiencies and reduce costs, the company has elected to locate the new analytical facility in China.  The company's core business services, current analytical laboratory, and commercial manufacturing will remain in the U.S.  The China facility is expected to open May 1st, 2010 but Gorbec is already working with customers who have plans to use some of the new facility's capacity.

The Yanti facility will operate under the direction of Gorbec's Vice President of Analytical Chemistry, Dr. Jing Chen.  Dr. Chen received her PhD from Stanford University and brings a wealth of pharmaceutical experience to the operation.  She joined Gorbec after holding various positions at Genentech Inc. and Alza Corporation.  Working with Dr. Chen will be Yan Zhang who will oversee the daily operations locally in Yantai.

Gorbec's Founder and CEO, Mike Gorman added, "We are very excited about our future and our ability to offer a GMP laboratory in China.  This new location will allow us to serve our own needs as well as the needs of companies looking to develop and distribute pharmaceutical products for the Asian Market."

About Gorbec

Gorbec Pharmaceutical Services, Inc. is a privately held company providing complete pharmaceutical development and manufacturing services.  Gorbec's highly experienced management team has driven the company to become a leader in the field of cGMP contract manufacturing services.  The company is focused primarily on the development of new drugs products that fill specialty niches within the traditional segment of the pharmaceutical business.

SOURCE Gorbec Pharmaceutical Services, Inc.

RELATED LINKS
http://www.gorbec.com

'/>"/>

SOURCE Gorbec Pharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
2. Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
3. Americas Pharmaceutical Research Companies Donate $35 Million to Relief Efforts in Haiti; More Help Coming
4. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
5. ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
6. ISTA Pharmaceuticals Announces Preliminary, Unaudited Revenue of $110.6 Million in 2009
7. Americas Pharmaceutical Research Companies Donate $25 Million to Relief Efforts in Haiti; More Help Coming
8. Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing
9. New Research from Best Practices Can Save Biopharma Companies Millions: Pharmaceutical New Product Planning - Structure and Activities to Drive Profitability
10. Ophthalmic Pharmaceutical Drugs - A Global Market Perspective
11. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized by ... Workplaces National Standard. To learn more about Diplomat,s ... ... ... administered by WorkplaceDynamics, LLC, a research firm specializing in organizational health ...
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... Research and Markets has announced the addition of the ... Application, Usability - Forecast to 2025" report to their offering. ... , , ... grow at a CAGR of around 3.2% from 2015 to 2025. ... advancements in extracellular microelectrode arrays and intracellular microelectrodes, research in left-to-right ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center ... loss and wellness program, at their world headquarters of Omni La Costa Resort & ... results to anyone seeking weight loss, personal development, a healthy lifestyle, or mental and ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased ... a convenient service for Texas, they are expanding their presence in Dallas. One of ... spree that will bring new jobs to the Dallas and Forth Worth market. STAT ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... planning services from offices headquartered in Little Rock, has initiated a charity drive ... to the National Foundation to End Senior Hunger, Arkansas ranks first in senior ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Compretta Insurance Agency, a family ... in and around the Hancock County area, is announcing the launch of a charity ... , The Hancock County Food Pantry has worked for more than 30 years to ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Today, MHA and ... comprehensive mental health systems reform legislation in more than fifty years. We applaud ... commitment of our elected officials to improving mental health services and supports in ...
Breaking Medicine News(10 mins):